PH10 (drug)

PH10 (drug)
Clinical data
Routes of
administration		 Intranasal
Identifiers
Synonyms PH10A; PH10 NS

PH10 is a vomeropherine that is under development by Pherin Pharmaceuticals as a nasal spray for the treatment of major depressive disorder.[1][2] In a small phase II clinical study, PH10 demonstrated rapid antidepressant effects, taking effect by 1 week (the first scheduled assessment; future studies will check to see if the antidepressant effects onset even sooner).[1][2] In addition, the effect sizes were found to be quite large (Cohen’s d value of 1.01 for high-dose PH10 and placebo, and Cohen’s d value of 0.71 for low-dose PH10 versus placebo).[1][2] 60–80% of patients achieved remission from depression.[1][2] PH10 was well-tolerated, with adverse effects including somnolence, nasal irritation, and headache.[1][2]

See also

References

  1. 1 2 3 4 5 Liebowitz, MR; Nicolini, H; Monti, L; Hanover, R (2013). "PH 10 may be a new rapidly acting intranasally administered antidepressant". American Society of Clinical Psychopharmacology (ASCP) Annual Meeting, Miami, FL.
  2. 1 2 3 4 5 Jancin, Bruce (2013). "Novel intranasal antidepressant shows results after 1 week". Clinical Psychiatry News. Retrieved 13 January 2016.




This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.